KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Oregon

HB3082 • 2025

Requires prescription drug manufacturers to report to the Department of Consumer and Business Services the total number of consumers to which the manufacturer offered a patient assistance program who participated in the program, notwithstanding any increase in the price of the prescription drug for which the manufacturer offered the program.

Requires prescription drug manufacturers to report to the Department of Consumer and Business Services the total number of consumers to which the manufacturer offered a patient assistance program who participated in the program, notwithstanding any increase in the price of the prescription drug for which the manufacturer offered the program.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Representative Levy E, Representative Javadi,, Senator Broadman,
Last action
2025-06-27
Official status
In House Committee
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2025-06-27 House

    In committee upon adjournment.

  2. 2025-04-09 House

    Motion to rerefer to Behavioral Health and Health Care carried. Rereferred.

  3. 2025-04-08 House

    Rules suspended. Carried over to April 9, 2025 Calendar.

  4. 2025-04-07 House

    Recommendation: Do pass.

  5. 2025-04-07 House

    Second reading.

  6. 2025-04-01 House

    Work Session held.

  7. 2025-02-25 House

    Public Hearing held.

  8. 2025-01-17 House

    Referred to Behavioral Health and Health Care.

  9. 2025-01-13 House

    First reading. Referred to Speaker's desk.

Official Summary Text

Digest: Tells a person that makes drugs and offers help in paying for the drugs to report to a state agency the number of people who used the help the person offered. Tells the person to do the report even if the price of the drug did not go up. (Flesch Readability Score: 74.9).
Requires prescription drug manufacturers to report to the Department of Consumer and Business Services the total number of consumers to which the manufacturer offered a patient assistance program who participated in the program, notwithstanding any increase in the price of the prescription drug for which the manufacturer offered the program.
Relating to: Relating to reporting obligations for patient assistance programs for prescription drug purchases.
Current location: In House Committee